Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burch

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Physical Chemistry Letters|August 9, 2023
Quantum Computation of Hydrogen Bond Dynamics and Vibrational SpectraPhilip Richerme, Melissa C Revelle, Christopher G Yale, et al.
Journal of Virology|November 16, 2018
Recessive Host Range Mutants and Unsusceptible Cells That Inactivate Virions without Genome Penetration: Ecological and Technical ImplicationsAaron P Roznowski, Robert J Young, Samuel D Love, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2014
Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitorsRichard M Pastor, Jason D Burch, Steven Magnuson, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptorJason D Burch, Julie Farand, John Colucci, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptorJason D Burch, Michel Belley, Réjean Fortin, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided HybridizationPatrick Cyr, Lee D Fader, Jason D Burch, et al.
Journal of Medicinal Chemistry|June 12, 2014
Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitorsJason D Burch, Kevin Lau, John J Barker, et al.
Journal of Medicinal Chemistry|April 7, 2015
Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in VivoJason D Burch, Kathy Barrett, Yuan Chen, et al.
Communications Chemistry|March 23, 2025
Structural insight into the cGAS active site explains differences between therapeutically relevant speciesAlexander M Skeldon, Li Wang, Nicolas Sgarioto, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)Giancarlo Trani, John J Barker, Steven M Bromidge, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Physical Chemistry Letters|August 9, 2023
Quantum Computation of Hydrogen Bond Dynamics and Vibrational SpectraPhilip Richerme, Melissa C Revelle, Christopher G Yale, et al.
Journal of Virology|November 16, 2018
Recessive Host Range Mutants and Unsusceptible Cells That Inactivate Virions without Genome Penetration: Ecological and Technical ImplicationsAaron P Roznowski, Robert J Young, Samuel D Love, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2014
Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitorsRichard M Pastor, Jason D Burch, Steven Magnuson, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptorJason D Burch, Julie Farand, John Colucci, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptorJason D Burch, Michel Belley, Réjean Fortin, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided HybridizationPatrick Cyr, Lee D Fader, Jason D Burch, et al.
Journal of Medicinal Chemistry|June 12, 2014
Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitorsJason D Burch, Kevin Lau, John J Barker, et al.
Journal of Medicinal Chemistry|April 7, 2015
Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in VivoJason D Burch, Kathy Barrett, Yuan Chen, et al.
Communications Chemistry|March 23, 2025
Structural insight into the cGAS active site explains differences between therapeutically relevant speciesAlexander M Skeldon, Li Wang, Nicolas Sgarioto, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)Giancarlo Trani, John J Barker, Steven M Bromidge, et al.
Pageof 11